Project Grant R01DA064978
Award Date 2/15/26
Completion Date 12/31/30
Dollars Obligated $677K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
South Miami, FL 33146, USA
Similar Awards
- Federal Grant Award Summary The National Institute on Drug Abuse awarded University of Miami $677,250 under the Drug Use and Addiction Research Programs (CFDA 93.279) on June 15, 2025, for development and testing of the Healthcare Empowerment and Advocacy for Recovery from Trafficking (HEART) intervention. The project, extending through May 31, 2028, addresses the intersecting public health emergencies of sex trafficking, opioid use disorder, and HIV epidemic by creating a peer-delivered brief...
- Federal Grant Award Summary The University of Miami's Office of Research Administration received a $1,066,077 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded August 18, 2025, with completion targeted for July 31, 2030. This Type 3 hybrid effectiveness-implementation study, titled "PrEP & Soccer," evaluates a multicomponent, multilevel implementation strategy...
- Federal Grant Award Summary The University of South Carolina received a $631,513 Project Grant award from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279), effective February 15, 2026, through December 31, 2030. This research project investigates modifiable factors affecting the HIV care continuum for people with HIV (PWH) experiencing concurrent substance use (SU) and mental health (MH) comorbidities. The study addresses health disparities...
- Federal Grant Award Summary The University of Miami received a $176,083 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), awarded on September 22, 2025, with completion targeted for August 31, 2030. This grant supports the planning and implementation of "Familias con Orgullo" (Families with Pride), a family-based intervention designed to prevent HIV infection, substance use, and mental health problems...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $1,573,958 Project Grant to the University of California, San Diego (effective August 1, 2025, through April 30, 2030) under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct implementation research on HIV elimination strategies. The grant funds a hybrid Type I trial at a large Federally Qualified Health Center (FQHC) network in Chicago that primarily serves sexual and gender minorities....
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Tulane University a $426,036 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and evaluate the feasibility and acceptability of "TRIPP," a virtual reality (VR)-based mindfulness intervention designed to support people with comorbid HIV and substance use disorders (PWHS). The award, effective July 15, 2025, through June 30, 2027, addresses a critical public health gap...
- Federal Grant Award Summary Rhode Island Hospital, a division of Lifespan Corporation, received a $573,320 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) effective August 1, 2025, through April 30, 2028. The grant supports the development and preliminary testing of a nurse-led, same-day HIV pre-exposure prophylaxis (PrEP) initiation intervention designed for incarcerated individuals at heightened risk for...
- Summary of Federal Project Grant Award The University of Florida received a $779,327 Project Grant award dated August 15, 2025, from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop PROTECT (Prediction of Relapse on OUD Treatment using Machine Learning-Driven Evidence-Based Clinical Decision Support Tool). The primary deliverable is an innovative machine learning algorithm and accompanying evidence-based clinical decision...
- Federal Grant Award Summary The University of Washington received a $672,701 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) on February 15, 2026, with a completion date of November 30, 2030. This research initiative will implement HIV screening and prevention services within low-barrier office-based opioid treatment (OBOT) programs at Harborview Medical Center in Seattle, Washington, supporting the federal...
- Federal Project Grant Award Summary Columbia University received a $246,012 Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) effective September 1, 2025, through June 30, 2028. The award supports the development and evaluation of a digital crowdsourced intervention designed to increase HIV, sexually transmitted infection (STI), and hepatitis C virus (HCV) testing uptake and overdose prevention kit utilization among survivors...